How second-line injectable drugs work

Armand Van Deun; Tom Decroo

doi:10.1093/cid/ciaa1874

How second-line injectable drugs work

Armand Van Deun, Tom Decroo

HIV and Tuberculosis

Research output: Contribution to journal › Letter › peer-review

7 Downloads (Pure)

Original language	English
Journal	Clinical Infectious Diseases
Volume	72
Issue number	12
Pages (from-to)	e1167-e1168
Number of pages	2
ISSN	1058-4838
DOIs	https://doi.org/10.1093/cid/ciaa1874
Publication status	Published - 2021

Keywords

RESISTANT TUBERCULOSIS
GATIFLOXACIN
MOXIFLOXACIN
PULMONARY
OUTCOMES

Access to Document

10.1093/cid/ciaa1874Licence: Other

2021cidie1167Final published version, 159 KBLicence: Other

Cite this

@article{3b25562499f640c9a3e00c06e977b4d3,

title = "How second-line injectable drugs work",

keywords = "RESISTANT TUBERCULOSIS, GATIFLOXACIN, MOXIFLOXACIN, PULMONARY, OUTCOMES",

author = "{Van Deun}, Armand and Tom Decroo",

note = "FTX; NOOA",

year = "2021",

doi = "10.1093/cid/ciaa1874",

language = "English",

volume = "72",

pages = "e1167--e1168",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - How second-line injectable drugs work

AU - Van Deun, Armand

AU - Decroo, Tom

N1 - FTX; NOOA

PY - 2021

Y1 - 2021

KW - RESISTANT TUBERCULOSIS

KW - GATIFLOXACIN

KW - MOXIFLOXACIN

KW - PULMONARY

KW - OUTCOMES

U2 - 10.1093/cid/ciaa1874

DO - 10.1093/cid/ciaa1874

M3 - Letter

SN - 1058-4838

VL - 72

SP - e1167-e1168

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 12

ER -